Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-20

Clinical Trial Update: CraniSeal Post Approval Study [Phase 4]

View source ↗

Summary

Phase 4 post-approval clinical trial update for CraniSeal. The study evaluating CraniSeal for cerebrospinal fluid leaks is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CraniSeal

Snippet

Sponsor: Pramand LLC | Conditions: Leak, Cerebrospinal Fluid | Phase 4 | Status: RECRUITING